Healthy Skepticism Library item: 6577

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Lexchin J.
Re: the promotion of Halfan (halofantrine)
1995 Mar;

Abstract:

The Pakistani subsidiary of SmithKline Beecham is promoting Halfan (halofantrine) for all types of malaria and is claiming an excellent safety profile. The scientific literature raises some questions about these claims.

Keywords:
*analysis/Pakistan/developing countries/Halfan/halofantrine/malaria/SmithKline Beecham/safety & risk information/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES